<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03167905</url>
  </required_header>
  <id_info>
    <org_study_id>2017/2090</org_study_id>
    <nct_id>NCT03167905</nct_id>
  </id_info>
  <brief_title>CODEPAD (Collaborative Outcomes of DEpression and Pain Associated With Delivery)</brief_title>
  <acronym>CODEPAD</acronym>
  <official_title>Comparison of the Role of Epidural Analgesia Versus Non-epidural Analgesia in Postnatal Depression and Persistent Pain Development: a Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>KK Women's and Children's Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>KK Women's and Children's Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Postnatal depression affects about 10-15% of women after childbirth. Approximately 3-5% of
      women experience a moderate-to-severe depression that requires medical attention. This study
      aims to investigate the implication of pain relief choice in reducing the postnatal
      depression of women who deliver their babies.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      If the patients have not decided on which pain relief method to be used, and would like to
      take part in this study, they will be assigned to either epidural or non-epidural pain relief
      for labour based on the study randomization result. Blood samples will be drawn to study the
      presence of known functional polymorphisms in candidate genes associated with depression,
      pain, stress and anxiety. Patients will be followed up with study questionnaires related to
      pain and postnatal depression screening during the study.

      During any time of the labour period, the patient is allowed to switch the pain relief option
      upon request.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 15, 2017</start_date>
  <completion_date type="Anticipated">March 16, 2020</completion_date>
  <primary_completion_date type="Anticipated">January 16, 2020</primary_completion_date>
  <phase>Phase 2/Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Cross over or switch to the other group of analgesia is allowed.</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The incidence of postnatal depression in both groups</measure>
    <time_frame>6-10 weeks after delivery</time_frame>
    <description>Edinburgh Postnatal Depression Scale (EPDS) score&gt;13</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>The incidence of acquiring post-delivery persistent pain in both groups</measure>
    <time_frame>6-10 weeks after delivery</time_frame>
    <description>Pain score&gt;3 in the perineal, surgical scar or abdomen region that lasts for at least 6 weeks post-delivery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain vulnerability in both groups (1)</measure>
    <time_frame>Upon recruitment until 6-10 weeks after delivery</time_frame>
    <description>Assessment via Pain Catastrophizing Scale (PCS) questionnaire before and after delivery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain vulnerability in both groups (2)</measure>
    <time_frame>Upon recruitment until 6-10 weeks after delivery</time_frame>
    <description>Assessment via Central Sensitisation Inventory (CSI) questionnaire before and after delivery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Psychological vulnerability in both groups (1)</measure>
    <time_frame>Upon recruitment until 5 days after delivery</time_frame>
    <description>Assessment via Fear-Avoidance Components Scale (FACS) questionnaire before delivery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Psychological vulnerability in both groups (2)</measure>
    <time_frame>Upon recruitment until 5 days after delivery</time_frame>
    <description>Assessment via State Trait Anxiety Inventory (STAI) questionnaire before delivery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Psychological vulnerability in both groups (3)</measure>
    <time_frame>Upon recruitment until 5 days after delivery</time_frame>
    <description>Assessment via Perceived Stress Scale (PSS) questionnaire before delivery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain severity in both groups</measure>
    <time_frame>During labour till one day after delivery</time_frame>
    <description>Pain score&gt;3 during labour</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">1326</enrollment>
  <condition>Depression, Postpartum</condition>
  <condition>Analgesia, Obstetrical</condition>
  <condition>Anesthesia, Obstetrical</condition>
  <arm_group>
    <arm_group_label>Epidural group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients are assigned to receive epidural delivery system (fentanyl and ropivacaine) for labour as pain relief option.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Non-epidural group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients are assigned to receive entonox (laughing gas), meperidine (pethidine) or remifentanil (Ultiva) for labour as pain relief option.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Epidural delivery system</intervention_name>
    <description>Epidural delivery system for maintenance of labour epidural analgesia using 0.1% ropivacaine (amide local anaesthetic) with 2mcg/ml fentanyl (opioid) as maintenance solution.</description>
    <arm_group_label>Epidural group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Entonox</intervention_name>
    <description>Entonox will be given upon request in non-epidural group.</description>
    <arm_group_label>Non-epidural group</arm_group_label>
    <other_name>Laughing gas</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Meperidine</intervention_name>
    <description>Intramuscular pethidine (75mg/1.5ml) will be given upon request in non-epidural group.</description>
    <arm_group_label>Non-epidural group</arm_group_label>
    <other_name>Pethidine</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ultiva</intervention_name>
    <description>Intravenous patient controlled remifentanil (20-40mcg/ml) is only given when the patient rejects or cannot receive pethidine and entonox in non-epidural group..</description>
    <arm_group_label>Non-epidural group</arm_group_label>
    <other_name>Remifentanil</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Fentanyl</intervention_name>
    <description>Epidural delivery system for maintenance of labour epidural analgesia using 0.1% ropivacaine (amide local anaesthetic) with 2mcg/ml fentanyl (opioid) as maintenance solution.</description>
    <arm_group_label>Epidural group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ropivacaine</intervention_name>
    <description>Epidural delivery system for maintenance of labour epidural analgesia using 0.1% ropivacaine (amide local anaesthetic) with 2mcg/ml fentanyl (opioid) as maintenance solution.</description>
    <arm_group_label>Epidural group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Healthy adult (American Society of Anesthesiologists physical status 1 and 2)
             parturients at term (36 weeks gestation or more) (nulliparous and multiparous);

          -  With a singleton fetus.

        Exclusion Criteria:

          -  Multiple pregnancies;

          -  Non-cephalic fetal presentation;

          -  Obstetric complications (e.g. pre-eclampsia, uncontrolled hypertension, uncontrolled
             diabetes);

          -  Elective and urgent caesarean section (not from delivery suite).
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ban Leong Sng, FANZCA</last_name>
    <role>Principal Investigator</role>
    <affiliation>KK Women's and Children's Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Ban Leong Sng, FANZCA</last_name>
    <phone>+6563941081</phone>
    <email>sng.ban.leong@kkh.com.sg</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Alex Tiong Heng Sia, MMED+</last_name>
    <phone>+6563941081</phone>
    <email>Alex.Sia.TH@kkh.com.sg</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>KK Women's and Children's Hospital</name>
      <address>
        <city>Singapore</city>
        <zip>229899</zip>
        <country>Singapore</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ban Leong Sng, FANZCA</last_name>
      <phone>+6563941081</phone>
      <email>sng.ban.leong@kkh.com.sg</email>
    </contact>
    <contact_backup>
      <last_name>Alex Tiong Heng Sia, MMED+</last_name>
      <phone>+6563941081</phone>
      <email>alex.sia.th@kkh.com.sg</email>
    </contact_backup>
    <investigator>
      <last_name>Ban Leong Sng, FANZCA</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Singapore</country>
  </location_countries>
  <verification_date>April 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 2, 2017</study_first_submitted>
  <study_first_submitted_qc>May 24, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">May 30, 2017</study_first_posted>
  <last_update_submitted>August 18, 2017</last_update_submitted>
  <last_update_submitted_qc>August 18, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">August 22, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Anesthesia, Obstetrical</keyword>
  <keyword>Epidural anesthesia</keyword>
  <keyword>Postnatal depression</keyword>
  <keyword>Persistent pain</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Depression</mesh_term>
    <mesh_term>Depressive Disorder</mesh_term>
    <mesh_term>Depression, Postpartum</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fentanyl</mesh_term>
    <mesh_term>Remifentanil</mesh_term>
    <mesh_term>Meperidine</mesh_term>
    <mesh_term>Nitrous Oxide</mesh_term>
    <mesh_term>Ropivacaine</mesh_term>
    <mesh_term>Entonox</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

